Chemotherapy-induced neuropathy
- PMID: 17588354
- DOI: 10.1007/s11912-007-0036-x
Chemotherapy-induced neuropathy
Abstract
Peripheral neuropathy is a common dose-limiting toxicity of chemotherapy. Chemotherapy-induced peripheral neuropathy (CIPN) causes numerous debilitating symptoms, impairs functional capacity, and results in dose reductions or possible cessation of chemotherapy. Analgesic or neurotropic agents are only modestly effective in treating neuropathic symptoms. Animal and human studies into the pathogenesis of CIPN have demonstrated heterogeneity in the mechanism(s) of nerve injury caused by individual agents, which may partly explain the wide variation in the resultant symptoms. Development of optimal therapeutic measures to treat CIPN requires continued research into the pathophysiologic basis of nerve injury, identification of risk factors for individual patients, development of reproducible and easy-to-use measurement scales, and finally, the performance of appropriately designed clinical trials to evaluate potentially promising agents.
Similar articles
-
[Peripheral neuropathy as a side effect of chemotherapy and targeted therapy].Dtsch Med Wochenschr. 2018 Jul;113(13):970-978. doi: 10.1055/s-0043-120839. Epub 2018 Jul 4. Dtsch Med Wochenschr. 2018. PMID: 29972842 Review. German.
-
[Chemotherapy-induced peripheral neuropathy: Symptomatology and epidemiology].Bull Cancer. 2018 Nov;105(11):1020-1032. doi: 10.1016/j.bulcan.2018.07.009. Epub 2018 Sep 20. Bull Cancer. 2018. PMID: 30244980 Review. French.
-
Chemotherapy-Induced Peripheral Neuropathy: Causative Agents, Preventative Strategies, and Treatment Approaches.J Pain Palliat Care Pharmacother. 2020 Sep;34(3):141-152. doi: 10.1080/15360288.2020.1734144. Epub 2020 Mar 2. J Pain Palliat Care Pharmacother. 2020. PMID: 32118502 Review.
-
Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.Ann Pharmacother. 2008 Oct;42(10):1481-5. doi: 10.1345/aph.1L179. Epub 2008 Aug 12. Ann Pharmacother. 2008. PMID: 18698011 Review.
-
Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.Support Care Cancer. 2018 Apr;26(4):1019-1028. doi: 10.1007/s00520-017-4013-0. Epub 2017 Dec 14. Support Care Cancer. 2018. PMID: 29243164 Free PMC article. Clinical Trial.
Cited by
-
A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).Support Care Cancer. 2017 Jan;25(1):195-204. doi: 10.1007/s00520-016-3404-y. Epub 2016 Sep 9. Support Care Cancer. 2017. PMID: 27612466 Clinical Trial.
-
Increased interleukin-6 activity associated with painful chemotherapy-induced peripheral neuropathy in women after breast cancer treatment.Nurs Res Pract. 2010;2010:281531. doi: 10.1155/2010/281531. Epub 2010 Aug 10. Nurs Res Pract. 2010. PMID: 21994811 Free PMC article.
-
The anticonvulsant enaminone E139 attenuates paclitaxel-induced neuropathic pain in rodents.ScientificWorldJournal. 2013 Dec 8;2013:240508. doi: 10.1155/2013/240508. eCollection 2013. ScientificWorldJournal. 2013. PMID: 24385872 Free PMC article.
-
PPARgamma Inhibitors as Novel Tubulin-Targeting Agents.PPAR Res. 2008;2008:785405. doi: 10.1155/2008/785405. PPAR Res. 2008. PMID: 18509498 Free PMC article.
-
The Role of Intravesicular Proteins and the Protein Corona of Extracellular Vesicles in the Development of Drug-Induced Polyneuropathy.Curr Issues Mol Biol. 2023 Apr 7;45(4):3302-3314. doi: 10.3390/cimb45040216. Curr Issues Mol Biol. 2023. PMID: 37185740 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical